Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBiz"The Perfect Storm of Patent Reform?'
By Lawrence B. Ebert, Esq.
Barbara Caulfield, partner, Dewey & LeBeouf, East Palo Alto
Colleen Chien, assistant professor of law, Santa Clara University
Mark Lemley, professor of law, Stanford University
Doug Luftman, associate general counsel, intellectual property, Palm Inc., Sunnyvale
Chip Lutton, chief patent counsel, Apple Inc.
Robert Merges, professor of law and technology, UC Berkeley
Paul R. Michel, chief judge, U.S. Court of Appeals for the Federal Circuit
Lynn Pasahow, partner, Fenwick & West
Sanjay Prasad, head, enterprise software licensing, Intellectual Ventures
Jerry Selinger, partner, Morgan, Lewis & Bockius LLP and former director, American Intellectual Property Law Association
Andrew Serafini, partner, Fenwick & West
Jay Thomas, professor of law, Georgetown University
Stratton Sclavos, former CEO, VeriSign Inc., Mountain View (luncheon keynote speaker)
Barbara A. Caulfield was Executive Vice-President and General Counsel of Affymetrix, Inc., in Sunnyvale, CA.
Colleen Chien, a registered patent attorney, was at Stanford School of Law (Center for Law and the Biosciences) in 2006 and graduated from University of California, Berkeley, School of Law (Boalt Hall), J.D., 2002, and thus has ties to Mark Lemley, who is not a registered patent attorney. She joined Santa Clara in 2007.
One can view Luftman.
Lynn Pasahow graduated from University of California, Berkeley, School of Law (Boalt Hall), J.D., Order of the Coif 1972
Stanford University, B.A., Phi Beta Kappa, 1969
Selinger was quoted by Nature in 2003 related to the whistleblower case concerning Taq:
Promega reached the sum of $1 billion by claiming triple damages, as allowed by the law, plus a $10,000 charge for each time a Taq purchase generated royalties for Roche. "This looks like a chance to go for big bucks," says Jerry Selinger, a Dallas patent lawyer and board member of the American Intellectual Property Law Association.
But Selinger and others don't give the suit much chance of success. For one thing, the Department of Justice, after reviewing the lawsuit's claims, declined to participate in prosecuting it. And although the future of Roche's Taq patent is uncertain in the United States, the European Patent Office issued a final ruling upholding it on 30 October.
See also
http://ipbiz.blogspot.com/2008/09/ta-tah-to-quillenwebsterlemley.html
http://ipbiz.blogspot.com/2008/08/lex-luther-vanquishes-four-amigos-of.html
Full post as published by IPBiz on October 12, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Texas, USA
alleging the Medical Malpractice and Tort Reform Act of 2003 violates several provisions of the Constitution.
Clean Water Act
Lexington-Fayette County agrees to spend $250 million to fix its sanitary and storm sewer systems.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment

Alnylam CEO Forecasts "Perfect Storm" for Biomedical Patents
White House Opposes Patent Reform Acts Limit on Damage Calculations
Vote on Patent Reform Delayed; Senators Remain Optimistic
How Patent Reform is like a Sombrero








